Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Thrombosis and Thrombolysis|November 3, 2009
Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patientMichael Makris, Joost J van Veen, Rhona Maclean
British Journal of Haematology|September 25, 2009
The risk of spinal haematoma following neuraxial anaesthesia or lumbar puncture in thrombocytopenic individualsJoost J van Veen, Timothy J Nokes, Mike Makris
Blood Transfusion = Trasfusione Del Sangue|February 11, 2009
Blood product support for delivery in severe factor X deficiency: the use of thrombin generation to guide therapyJoost J van Veen, Kingsley K Hampton, Rhona Maclean, et al.
Haematologica|July 2, 2013
Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia AAnnette E Bowyer, Joost J Van Veen, Anne C Goodeve, et al.
International Journal of Laboratory Hematology|November 10, 2021
Laboratory methods for monitoring argatroban in heparin-induced thrombocytopeniaSusan Guy, Steve Kitchen, Barbara Hopkins, et al.
Thrombosis and Haemostasis|August 12, 2008
Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitroAlex Gatt, Joost J van Veen, Anita M Woolley, et al.
Thrombosis Research|November 18, 2008
Calibrated automated thrombin generation and modified thromboelastometry in haemophilia AJoost J van Veen, Alex Gatt, Annette E Bowyer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 5, 2008
Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parametersJoost J van Veen, Alex Gatt, Peter C Cooper, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 2011
Protamine reversal of low molecular weight heparin: clinically effective?Joost J van Veen, Rhona M Maclean, Kingsley K Hampton, et al.
British Journal of Haematology|March 9, 2022
Von Willebrand factor assays in patients with acquired immune thrombotic thrombocytopenia purpura treated with caplacizumabAnnette Bowyer, Paula Brown, Barbara Hopkins, et al.
Pageof 2